MT 63-78
- Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
- Dry Ice Shipment: No


MT 63-78
Description :
MT 63-78 is a specific and potent direct AMPK activator with an EC50 of 25 μM. MT 63–78 also induces cell mitotic arrest and apoptosis. MT 63-78 blocks prostate cancer growth by inhibiting the lipogenesis and mTORC1 pathways. MT 63-78 has antitumor effects[1].CAS Number :
[1179347-65-9]UNSPSC :
12352005Hazard Statement :
H302, H315, H319, H335Target :
AMPK; Apoptosis; mTORType :
Reference compoundRelated Pathways :
Apoptosis; Epigenetics; PI3K/Akt/mTORApplications :
Cancer-Kinase/proteaseField of Research :
CancerAssay Protocol :
https://www.medchemexpress.com/mt-63-78.htmlPurity :
98.00Solubility :
DMSO : 125 mg/mL (ultrasonic)Smiles :
N#CC1=CNC2=C1C=C(C3=CC=C(C4=C(O)C=CC=C4O)C=C3)C=C2Molecular Formula :
C21H14N2O2Molecular Weight :
326.35Precautions :
H302, H315, H319, H335References & Citations :
[1]Zadra G, et al. A novel direct activator of AMPK inhibits prostate cancer growth by blocking lipogenesis. EMBO Mol Med. 2014 Apr;6 (4) :519-38.Shipping Conditions :
Room TemperatureStorage Conditions :
4°C (Powder, protect from light)Scientific Category :
Reference compound1Clinical Information :
No Development ReportedIsoform :
AMPK; mTORC1

